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d-aminolevulinic acid (ALA) is the precursor in the biosynthesis of porphyrins. The knowledge of both the regulation of ALA entrance
and efflux from the cells and the control of porphyrin biosynthesis is essential to improve ALA-mediated photodynamic therapy. In
this work, we studied the regulation of ALA uptake and efflux by endogenously accumulated ALA and/or porphyrins in murine
mammary adenocarcinoma cells. Under our set of conditions, the haem synthesis inhibitor succinyl acetone completely prevented
porphobilinogen and porphyrin synthesis from ALA, and led to an increase in the intracellular ALA pool. However, neither
intracellular ALA nor porphyrin pools regulate ALA uptake or efflux during the first 15min of the process. Based on temperature
dependence data, ALA but not g-aminobutyric acid (GABA) efflux is mediated by a diffusion mechanism. Moreover, the addition of
extracellular GABA not only did not influence the rate of ALA efflux but on the contrary it affected ALA uptake, showing the
contribution of a saturable mechanism for the uptake, but not for the efflux of ALA from the cells.
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d-aminolevulinic acid (ALA) is the precursor in the biosynthesis of
porphyrins, which in association with several proteins are essential
for the utilisation and metabolism of oxygen. The first step of the
porphyrin biosynthetic pathway is the synthesis of ALA by a
condensation reaction between succinyl CoA and glycine, catalysed
by the enzyme ALA synthase. This enzyme is rate limiting, tightly
regulated by feedback inhibition (Rimington, 1966). The second
rate limiting step in haem synthesis is the incorporation of ferrous
iron into protoporphyrin IX (PPIX), a reaction catalysed by the
enzyme ferrochelatase. Owing to this slow conversion of PPIX to
haem (Pottier et al, 1986) when exogenous ALA is administered,
high tissue levels of porphyrin intermediates are found (Malik and
Djaldetti, 1979; Sinna et al, 1981).
Photodynamic therapy (PDT) is a nonthermal technique for
inducing tissue damage with light following administration of a
light-activated photosensitising drug that can be selectively
retained in malignant or diseased lesions relative to normal
adjacent tissue (Dougherty et al, 1978). In addition, the
fluorescence of photosensitising chromophores has been exploited
for the visualisation and diagnosis of early-stage superficial
cancers (Kriegmair et al, 1996). It has been demonstrated that
sufficient PPIX, a potent photosensitiser, is synthesised by
exogenous ALA administration to produce a photodynamic effect
following exposure to light (Kennedy et al, 1990; Fukuda et al,
1993a).
ALA-induced PPIX accumulation has been shown to be
preferentially greater in certain tumoral cells (Navone et al,
1988), primarily due to the reduced activity of ferroquelatase and a
relative enhancement of porphobilinogen (PBG) deaminase
activity in these cells (Navone et al, 1991). The success of ALA-
mediated photosensitisation will depend on an efficient ALA
uptake, a low ALA efflux and an efficient conversion of ALA into
porphyrins.
Several reports regarding ALA uptake systems have appeared.
Thus, some authors demonstrated that ALA is taken up through
the di- and tripeptide transporters PEPT1 and PEPT2 (Do ¨ring et al,
1998; Novotny et al, 2000; Whitaker et al, 2000). Other authors
reported that BETA transporters are involved in ALA transport
(Rud et al, 2000). The BETA transporter family comprise GAT-1 to
GAT-3, BGT-1 and TAUT transport systems (Palacı ´n et al, 1998).
Using murine mammary adenocarcinoma cultured cells, we have
recently demonstrated that ALA is incorporated by two different
processes (Bermu ´dez Moretti et al, 2002). One of these processes is
passive diffusion that is significant at shorter incubation intervals.
The other is an active transport system that becomes very
important after the first 15min of incubation. The latter system
is mediated by one of the BETA transporters, very likely GAT-2
(Bermu ´dez Moretti et al, 2002).
The knowledge of both the regulation of ALA entrance into the
cells and the control of porphyrin biosynthesis is essential to
improve ALA-mediated PDT. In this work, we studied the
regulation of ALA uptake by endogenously accumulated ALA
and/or porphyrins in murine mammary adenocarcinoma cells. We
have also determined the nature of the ALA efflux process.
MATERIALS AND METHODS
Cell line and cell culture
Cell line LM3 (Werbajh et al, 1998) derived from the murine
mammary adenocarcinoma M3 was cultured in minimum essential
Eagle’s medium, supplemented with 2mML -glutamine, 40mg Received 30 January 2003; revised 4 April 2003; accepted 29 April 2003
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sgentamycinml
 1 and 5% fetal bovine serum, and incubated at
371C in an atmosphere containing 5% CO2. A total of
3.5 10
4cellswell
 1 were seeded into 24-well plates and the
medium was renewed 24h before the experiment.
Chemicals
[4-
14C]ALA hydrochloride and [
14C(U)]g-aminobutyric acid
(GABA) were obtained from New England Nuclear, ALA, GABA,
succinyl acetone (SA) and metabolic inhibitors were obtained from
Sigma Chemical Co., St Louis, USA. Other chemicals were of
analytical grade.
ALA and GABA preparation
Unlabelled ALA or GABA were dissolved in phosphate-buffered
saline (PBS) and pH was adjusted to 7.4 with NaOH. [
14C]ALA and
[
14C]GABA were added so that the final solution contained 0.0222
and 0.0111MBqml
 1, respectively.
Uptake measurements
Uptake measurements were performed 72h after seeding, when the
cells were nearly confluent. The cells were washed twice with 0.5ml
PBS–0.1% glucose preheated at 371C and incubated with 0.3ml
radiolabelled 0.6mM ALA or GABA prepared in PBS–0.1% glucose
at 371C. At the indicated times, the reaction was stopped by
washing the cells four times with 0.5ml ice-cold PBS containing
either 1mM ALA or 1mM GABA to remove nonspecific binding.
Then the cells were disrupted in 0.1mM NaOH and transferred to
vials containing scintillation fluid (OptiPhase-Hisafe 3, Perkin-
Elmer, England). The radioactive content of the samples was
determined.
Efflux experiments
The cells were loaded with 0.6mM
14C-ALA or
14C-GABA for
15min, washed four times with PBS containing either 1mM ALA or
1m M GABA to remove nonspecific binding and further incubated
with PBS at 371C. Radioactivity within the cells and in the medium
was measured at different times of incubation, after adding 0.1mM
NaOH.
ALA and PBG determinations
The cells were seeded in 100mm dishes. After 72h, the medium
was removed and the cells were exposed for 3h to 0.6mM ALA in a
medium without serum. Afterwards, the cells were washed four
times with PBS and 5% TCA was added. After scrapping, the cells
were centrifuged and the supernatant was employed for ALA and
PBG determinations. Modifications of the Mauzerall and Granick
(1956) method were used. Briefly, for ALA determination, a
condensation reaction was developed in the presence of acetyl
acetone and the resulting pyrroles were quantified by addition of
the Ehrlich reactive. For PBG determination, the Ehrlich reactive
was added to the deproteinised TCA supernatant. ALA values were
obtained by subtracting PBG values to the total condensed
pyrroles.
Porphyrin synthesis
Porphyrins accumulated within the cells were extracted twice with
5% HCl, leaving the cells standing for 30min in the presence of the
acid at 371C. For media determinations, 5% HCl was added and
measured directly. These conditions proved to be optimal for total
PPIX extraction. The excitation and emission wavelengths of light
used producing the highest fluorescence were 406 and 604nm,
respectively. PPIX (Porphyrin Products, Logan, UT, USA) was
used as a reference standard. All the experiments were performed
at 0.6mM ALA, because porphyrin synthesis is saturated at this
concentration.
Cell number
The number of cells seeded per well and employed for the
calculations were determined by counting viable cells with the
Trypan blue-exclusion method.
Statistic analysis
Quadruplicates were run for each point in every experiment and
the values presented are the average of three experiments
(mean7s.d.). The deviation of these values from the mean was
less than 15%. A paired Student’s t-test was used to determine
statistical significance between means. P values o0.05 were
considered significant.
RESULTS
Cells were incubated with 0.6mM ALA in the presence or absence
of 0.5mM SA for 3h, then ALA, PBG and porphyrins were
measured (Table 1). Upon exposure to 0.5mM SA, PBG and
porphyrin biosynthesis is completely eliminated. The presence of a
higher intracellular pool of ALA (105.477.1pmol10
 5 cells) is also
evidenced after SA exposure. At 3h after incubation with 0.6mM
ALA in the absence of SA, the intracellular ALA is almost
completely consumed and 15.171.1pmol PBG10
 5 cells and
13.070.7pmol porphyrin10
 5 cells are formed.
In Figure 1A, ALA uptake was measured in cells treated with SA.
We choose 0.1mM ALA for this experiment to minimize ALA
conversion (Bermu ´dez Moretti et al, 2002). When the cells were
preincubated for 20min with 0.5mM SA and this compound was
withdrawn before adding
14C-ALA, ALA incorporation is similar to
that found in control cells. Interestingly, the presence of SA during
the whole uptake assay does not modify ALA uptake.
Similarly, Figure 1B shows the effect of SA on GABA transport.
Again, there are no changes in GABA incorporation driven by the
presence of SA before or during the uptake assay.
In another set of experiments (data not shown), cells treated
with 0.5mM SA or not were preincubated with 0.6mM ALA for 15,
60 or 180min before measuring ALA uptake in order to achieve
increasing intracellular ALA or porphyrin pools. It was found that
initial ALA uptake rates remain constant (0.11370.015pmol
ALA10
 5 cellsmin
 1).
In Table 2, we studied the dependence on temperature of ALA
and GABA efflux. A 32% efflux of ALA is detected at 371C and
similar results were obtained when it was measured at 01C. In
contrast, GABA efflux decreases significantly to 18% when the
temperature is lowered to 01C.
Table 3 shows the results of ALA and porphyrin efflux in the
presence or absence of SA. After 15min of preloading with ALA, in
the absence of SA, a complete conversion of ALA into porphyrins
Table 1 Intracellular pools of ALA, PBG and porphyrins
 ALA SA +ALA SA +ALA+SA
ALA (pmol10
 5 cell) ND 13.0570.90 105.477.1
PBG (pmol10
 5 cell) ND 15.1271.10 ND
Porphyrins(pmol10
 5 cell) 0.5670.02 13.0170.70 0.3870.02
Cells were exposed for 3h to 0.6mM ALA in the presence or absence of 0.5mM SA
in a medium without serum. Afterwards, ALA, PBG and porphyrins were determined
according to the procedures described in Materials and Methods.  ALA+SA
controls (cells in the presence of SA without exposure to ALA) have been subtracted
from +ALA+SA values. ND: nondetectable by this method.
ALA uptake and efflux
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sis already observed at 60min, and under these conditions, 15% of
the intracellular tetrapyrrole accumulation is released to the
medium. The same pattern is observed at longer periods (180min).
When porphyrin synthesis is prevented by SA exposure, only basal
levels of tetrapyrroles are detected together with an intracellular
ALA pool.
We expressed as ALAþPBG, the result of the subtraction of
porphyrins from the total radiolabelled content, because at these
times, we are in the presence of ALA metabolisation in the case of
þALAþSA. Efflux of ALA/PBG to the medium is significantly
higher in the presence of SA both at 60 and 180min of incubation.
Table 4 shows porphyrin synthesis in cells exposed to ALA and
GABA. Intracellular porphyrins as well as porphyrins released to
the medium are 20% lower after coincubation with an equimolar
GABA concentration (ALAþGABA). When GABA is added after
withdrawal of ALA (þALA-GABA), porphyrin values are not
affected, showing that GABA does not modify ALA efflux, at least
to the extent of modifying porphyrin synthesis. These results
correlate well with an unchanged rate of
14C-ALA efflux upon
exposure to GABA or ALA after ALA preloading (data not
depicted). As expected, further incubation with ALA for 3h
(þALA-ALA) correlates with an increase in tetrapyrrole
formation.
DISCUSSION
To determine whether intracellular accumulated ALA affects its
transport process in murine mammary adenocarcinoma cells, ALA
metabolisation was prevented using SA, a specific competitive
inhibitor of ALA-dehydratase (Ebert et al, 1979). This enzyme
catalyses the condensation of two molecules of ALA to form PBG,
the pyrrolic precursor of porphyrins. We proved that under our set
of conditions (Table 1), SA completely eliminates PBG and
porphyrin synthesis from ALA in this adenocarcinoma cell line.
The presence of the inhibitor also leads to an increase of the
intracellular ALA pool.
After 3h of ALA exposure, in the absence of SA, 13.070.7pmol
porphyrin10
 5 cells were synthesised. A linear increase in
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Figure 1 ALA and GABA uptake in the presence of the haem inhibitor
SA. Cells were preincubated with 0.5mM SA and 0.1mM
14C-ALA (A)o r
GABA (B) uptake was measured in the presence or absence of SA.
Control, classical ALA uptake (n¼4).
Table 3 ALA and porphyrin efflux in the presence of the haem synthesis inhibitor SA
60min 180min
 SA +SA  SA +SA
ALA, PBG and porphyrins
a Intracellular 12.5071.31 9.5071.12 12.0971.02 11.2671.08
Extracellular 6.7970.54 8.0070.75 7.4370.84 10.5271.19
Porphyrins
b Intracellular 12.5070.9 2.6070.05 12.0970.7 4.3670.07
Extracellular 1.4070.04 ND 1.1170.06 ND
ALA and PBG
c Intracellular 072.20 6.9071.17 071.72 6.9071.15
Extracellular
d 5.3970.58 8.0070.75 6.3270.9 10.5271.19
Cells were preloaded for 15min with 0.6mM
14C-ALA, washed with PBS and further incubated for 60 and 180min at 371C. Intracellular and extracellular radioactivity was
quantified. In addition, porphyrins were quantified spectrophotometrically and expressed per 10
5 cells. In +SA experiments, 0.5mM of the haem synthesis inhibitor was present
during the preload and efflux incubations.
aAll expressed as pmol
14C-ALA, calculated as the addition of both intracellular and extracellular radioactivity.
bpmol ALA converted into porphyrins.
cExpressed as pmol ALA
calculated subtracting
b from
a, intracellular and extracellular, respectively.
dPo0.005. ND: nondetectable by this method.
Table 2 Dependence of ALA and GABA efflux on temperature
% of release
Efflux of 371C0 1C
ALA 32 31
GABA 35 18
Cells were preloaded for 15min with 0.6mM
14C-ALA or GABA, washed with PBS
containing either ALA or GABA, respectively, and further incubated for 15min at 37
or 01C. ALA or GABA released to the medium was calculated as a percentage of
intracellular radioactivity at 0min after ALA loading (initial intracellular pools).
ALA uptake and efflux
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sporphyrin synthesis up to 3h has been previously established for
this cell line (Bermu ´dez Moretti et al, 2002).
As it has already been shown, for 3h ALA exposure, the
incubation with ALA for different times in the presence or absence
of SA leads to the intracellular accumulation of ALA or porphyrins,
respectively. To determine the effect of different intracellular ALA
and porphyrin pools on ALA transport, we treated the cells with or
without SA before preincubating with ALA for different times and
before measuring ALA uptake (data not shown). We found that
neither ALA nor porphyrin pools regulate ALA incorporation,
since the initial ALA uptake rates remain constant. In addition, the
presence of SA during the whole assay without changing ALA
uptake demonstrates that SA does not compete for ALA uptake
(Figure 1), in good agreement with the findings of Gibson et al
(2001).
As it is well known that GABA is a substrate for the BETA
transporters (Palacı ´n et al, 1998), the effect of SA on GABA
transport was also examined and, as expected, there is no
competition between GABA and SA, and inhibition of ALA
metabolisation did not affect GABA uptake either.
The higher efflux of ALA/PBG in the presence of SA (Table 3)
may be a consequence of a high intracellular ALA pool due to an
impairment on the conversion of ALA into PBG, which in addition,
might be less diffusible than ALA.
According to temperature dependence data (Table 2), ALA
transport from the cytoplasm to the extracellular medium is
carried out by a diffusion process, at least after this short
incubation time period. On the other hand, only active transport
seems to be involved in GABA efflux. These were the expected
results since they are in agreement with our previous findings
(Bermu ´dez Moretti et al, 2002), where we demonstrated that ALA
is incorporated into these cells through two different mechanisms,
diffusion and an active process, while GABA uptake is not
mediated by diffusion.
When we expose cells to 0.6mM ALA for 15min, we can see that
after 60min of ALA withdrawal, all the ALA has been consumed
and porphyrin synthesis cannot be further increased by extending
the incubation time to 180min (Table 3). Some haem enzymes
such as ALA dehydratase and PBG deaminase have been
postulated to be rate limiting in the production of porphyrins
from ALA (Gibson et al, 1998, 2001). However, under our
conditions of short ALA exposure, ALA availability is limiting
tetrapyrrole formation.
GABA is a competitor for ALA uptake and a putative competitor
for ALA efflux. In an attempt to diminish ALA efflux, and
consequently, increase porphyrin synthesis, we exposed the cells to
equimolar GABA concentrations, after ALA preloading (Table 4).
However, neither ALA nor GABA affected ALA efflux, instead the
latter competed for ALA uptake. These data reinforce the
hypothesis that ALA efflux is mainly mediated by a diffusion
process, whereas ALA uptake even at short incubation times, is at
least in part mediated by a saturable transport mechanism.
Porphyrin release is kept to 15% independent of the incubation
times. This is a typical release of PPIX to a medium without serum,
and it has been previously reported by Fukuda et al (1993b) and
Iinuma et al (1994). Although it is not known whether this loss is
passive or whether it involves an active transport process (Fukuda
et al, 1993a,b), the different efflux rates observed by Iinuma et al
(1994) using different cell lines, suggest that the mechanism is not
simply mediated by diffusion. However, characterisation of the
mechanisms of PPIX efflux exceeds the aims of this paper.
This is the first study describing ALA efflux in a non-neural cell
line. We attempted to diminish such efflux to improve ALA
availability with the aim of increasing PDT efficacy. However, we
found that until 15min after preloading with ALA, a diffusion
process mediates efflux, and we could not modulate it by
employing putative competitors. Nevertheless, further studies
should be carried out to explore the possibility of inhibiting
ALA efflux at longer incubation times.
The design of new nondiffusible ALA derivatives would be an
approach to overcome the disadvantage of ALA efflux. In this
regard, taking into account the fact that GABA does not efflux
from cells, the structural differences between ALA and GABA
could be further exploited.
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